Form F-10/A - Registration Statement for Securities of certain Canadian Issuers.: [Amend]
SEC Accession No. 0001193125-21-002077
Filing Date
2021-01-05
Accepted
2021-01-05 17:29:17
Documents
10

Document Format Files

Seq Description Document Type Size
1 F-10/A d800188df10a.htm F-10/A 610357
2 EX-4.1 d800188dex41.htm EX-4.1 285476
3 EX-4.12 d800188dex412.htm EX-4.12 8365
4 EX-5.1 d800188dex51.htm EX-5.1 1708
5 EX-5.2 d800188dex52.htm EX-5.2 6737
6 EX-7.1 d800188dex71.htm EX-7.1 525345
7 GRAPHIC g800188dsp1.jpg GRAPHIC 10644
8 GRAPHIC g800188dsp5ajpg.jpg GRAPHIC 42959
9 GRAPHIC g800188g03v48.jpg GRAPHIC 58371
10 GRAPHIC g800188g54n18.jpg GRAPHIC 3713
  Complete submission text file 0001193125-21-002077.txt   1595245
Mailing Address 880 - 580 HORNBY STREET VANCOUVER A1 V6C3B6
Business Address 880 - 580 HORNBY STREET VANCOUVER A1 V6C3B6 6048060626
ImmunoPrecise Antibodies Ltd. (Filer) CIK: 0001715925 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0430
Type: F-10/A | Act: 33 | File No.: 333-249957 | Film No.: 21507320
SIC: 2834 Pharmaceutical Preparations